Read + Share
Amedeo Smart
Independent Medical Education
Yue CH, Chen CH, Lee WT, Su TF, et al. Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells Via Inactivation of c-Met/PI3K/Akt/mTOR Pathway. Anticancer Res 2020;40:4513-4522.PMID: 32727781
Email
LinkedIn
Facebook
Twitter
Privacy Policy